What is Pacira?
Pacira is a leading provider of non-opioid pain management and regenerative health solutions, dedicated to enhancing patient outcomes. Operating under the ticker symbol (Nasdaq: PCRX), the company focuses on developing and manufacturing innovative healthcare products. Its mission is to create a meaningful difference in the lives of patients, families, communities, and society through its advanced therapeutic offerings. The company's commitment to improving health and well-being positions it as a key player in the pharmaceutical and biotechnology landscape.
How much funding has Pacira raised?
Pacira has raised a total of $42M across 1 funding round:
Stock Offering
$42M
Stock Issuance/Offering (2011): $42M, investors not publicly disclosed
What's next for Pacira?
The substantial enterprise-level funding and recent strategic investment suggest Pacira is poised for accelerated expansion and further innovation in its specialized fields. This capital infusion is likely to support the advancement of its product pipeline, enhance its manufacturing capabilities, and broaden its market reach. As a publicly traded company, Pacira's strategic financing activities will be closely watched by investors and industry analysts, anticipating further developments in non-opioid pain management and regenerative medicine.
See full Pacira company page
